Revealing the Genetic Signature of Neurodegenerative Disease
Revealing the Genetic Signature of Neurodegenerative Disease
Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.
Gladstone Experts Multiple Sclerosis Alzheimer’s Disease Neurological Disease Akassoglou Lab